Description
Epigenetics is revolutionizing our understanding of health, aging, and disease—not just in humans, but in animals too. This webinar will explore the role of DNA methylation, one of the most studied epigenetic mechanisms, and how it is emerging as a powerful biomarker in human medicine for age estimation, health risk prediction, and personalized care. We will discuss how these findings are now being translated into veterinary science, with a focus on dogs and cats, to better understand their biological age, disease risk, and potential longevity interventions.
Participants will learn about the fundamentals of DNA methylation, recent breakthroughs in human epigenetic biomarker research, and how these discoveries might inform future diagnostics and preventative care in companion animals. By drawing these parallels, veterinary professionals can prepare for the next wave of innovation in precision pet health.
This session is ideal for veterinarians, researchers, and pet health industry professionals interested in cutting-edge diagnostics and the future of proactive care.
Let us know your thoughts on this session, via our survey: https://fm5tomq1td0.typeform.com/to/beRHmpO4
Learning Objectives
- Identify challenges and opportunities in integrating epigenetic testing into routine pet care
- Evaluate the translational potential of human epigenetic research for veterinary applications
- Recognize the potential for DNA methylation to serve as a diagnostic or preventative tool in veterinary practice
- Understand current research trends exploring the use of epigenetic biomarkers in pets, particularly dogs and cats
- Describe how DNA methylation biomarkers are currently used in human medicine to assess age, disease risk, and health status
- Explain the basic principles of epigenetics and DNA methylation
